Biodesix Inc SEC filings BDSX

Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.

Biodesix Inc SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Mar 3, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 1, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 12, 2023 Dec 31, 2022
10-K Annual report Mar 6, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2022 Dec 31, 2021
10-K Annual report Mar 16, 2021 Dec 31, 2020

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
BDSX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Louisville, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1439725

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.